Our Products

We are committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Our R&D efforts are focused on four key therapeutic areas: Gastroenterology (GI), Critical Illness, Rare Diseases and Neuroscience. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

Brand name	Generic name
Gastroenterology
Dexilant	Dexlansoprazole
Takepron	Lansoprazole
Pantoloc	Pantoprazole
Faktu	Policresulen/Cinchocaine
Entyvio	Vedolizumab
Mezavant	Mesalazine
Critical Illness
Adcetris	Brentuximab vedotin
Alunbrig	Brigatinib
Enantone	Leuprorelin acetate
Ninlaro	Ixazomib citrate
Rare Diseases
Advate	Octocog alfa Antihemophilic Factor (Recombinant)
Agrylin	Anagrelide
Feiba	Anti-inhibitor coagulant complex
Kiovig	Human Normal Immunoglobin (IVIg)
Neuroscience
Vyvanse	Lisdexamfetamine Dimesylate
Others
Fosrenol	Lanthanum Carbonate
Gutron	Midodrine
Ubretid	Distigmine

^{C-APROM/HK/CORP/0063 (01/2021)}